Cases 11 - 20 of 190
NEXUS PHARMACEUTICALS, INC. v. NEVAKAR, INC. et al
as 1:2022cv06030
Plaintiff:
NEXUS PHARMACEUTICALS, INC.
Defendant:
NEVAKAR, INC., NEVAKAR INJECTABLES, INC., PAR STERILE PRODUCTS, LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEXUS PHARMACEUTICALS, INC. v. NEVAKAR, INC. et al
as 1:2022cv05683
Plaintiff:
NEXUS PHARMACEUTICALS, INC.
Defendant:
NEVAKAR, INC., NEVAKAR INJECTABLES, INC., PAR STERILE PRODUCTS, LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 3:2022cv02814
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. DR. REDDY'S LABORATORIES, INC et al
as 3:2020cv18328
Defendant:
DR. REDDY'S LABORATORIES, LTD. and DR. REDDY'S LABORATORIES, INC
Plaintiff:
PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al
as 3:2020cv18334
Defendant:
AUROBINDO PHARMA U.S.A., INC. and AUROBINDO PHARMA LIMITED
Plaintiff:
PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. EAGLE PHARMACEUTICALS, INC.
as 3:2020cv18319
Defendant:
EAGLE PHARMACEUTICALS, INC.
Plaintiff:
PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. AMNEAL EU, LIMITED et al
as 3:2020cv18322
Defendant:
AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, AMNEAL BIOSCIENCES LLC, AMNEAL EU, LIMITED and others
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
as 1:2019cv02216
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
3Rd Party Defendant:
Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Intervenor:
Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
